The Eugene facility, with more than 20 years of history, houses a 16,000-square-foot R&D lab and a newly constructed 30,000-square-foot manufacturing facility
Treatment typically requires frequent injections directly into the eye—an ongoing burden for patients and health systems alike
The launch of PatroLab is a pivotal milestone, marking a paradigm shift in biologics development and manufacturing
Approval marks Venus Remedies’ first anti-infective marketing authorization in Indonesia and enables the country’s first generic entry for this critical antibiotic combination
The collaboration gives Axolabs access to Codexis’ innovative RNA manufacturing technology
Supports production of AbbVie's current and next-generation immunology and neuroscience medicines
The agreement responds directly to President Trump’s demands that drugmakers cut costs for US patients
ADHD is a common, chronic neurodevelopmental disorder that often begins in childhood and can persist into adulthood
The work will leverage ProBioGen’s CHO.RiGHT expression platform, powered by its proprietary DirectedLuck transposase technology, alongside PsiBot smart automation
SLE remains a life-threatening autoimmune disease, with patients facing an elevated risk of early mortality and long-term organ damage
Subscribe To Our Newsletter & Stay Updated
